Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.
So far, 2022 has been an ugly year for a lot of stocks. But if you look out over the next five years, you can find some amazing opportunities. Our roundtable of three Motley Fool contributors has found three biotech stocks that might be 11-baggers in five years.
Patrick Bafuma is bullish on Legend Biotech (NASDAQ: LEGN) and thinks it might be worth $55 billion by 2027. George Budwell believes his pick, Heron Therapeutics (NASDAQ: HRTX), could jump 1,000% in that time frame. And Taylor Carmichael feels tiny Pieris Pharmaceuticals (NASDAQ: PIRS) could leap from micro-cap to small-cap and pull off an 11-bagger in five years. Here's why we think these biotechs could seriously outperform the market.
Image source: Getty Images.
Source Fool.com
